Table 5.
Groups | WBCs ×103/UL |
RBCs ×106/UL |
PLT ×103/UL |
HGB (g/dL) |
HCT (%) |
---|---|---|---|---|---|
Control | 2.7 ± 0.09 | 8.8 ± 0.26 | 837 ± 42.7 | 14.1 ± 0.24 | 44.98 ± 0.7 |
EST | 10.9 ± 0.4a | 7.5 ± 0.5 | 1184 ± 70.2a | 9.6 ± 0.5a | 26.38 ± 0.7a |
EST + IRR | 0.8 ± 0.05a,b | 6.1 ± 0.2a | 105 ± 4.9a,b | 10.53 ± 0.5a | 26.5 ± 1.1a |
EST + BL | 5.1 ± 0.6a,b | 8.6 ± 0.7 | 670 ± 53.9b | 10.52 ± 0.4a | 33.9 ± 1a,b |
EST + BL + IRR | 2.1 ± 0.19b,c | 6.3 ± 0.08a | 317 ± 20a,b,c | 9.9 ± 0.1a | 33.5 ± 0.2a,b,c |
Abbreviations: EST, Ehrlich solid tumor; EST + IRR, Ehrlich solid tumor + irradiation; EST + BL, Ehrlich solid tumor + bromelain; EST + BL + IRR, Ehrlich solid tumor + bromelain + irradiation.
Each value represents the mean of 6 records ± SE, a: significant versus control group, where b: significant versus EST group and c: significant versus EST-irradiated group at P < .05.